Physician profile
Maximilian Martinez
NPI 1609261916
$16,998.38
in general payments reported to CMS, 2019-2025
9 companies · $485 in 2025
The $485 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,216 · 2022: $5,178 · 2023: $3,013 · 2024: $2,106 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,361 · Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,360.97 |
| Food and Beverage | $1,243.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,656.46 | 2021-2023 | |
| Smith+Nephew, INC. | $4,473.74 | 2021-2025 | Journey II, Real Intelligence, Ri Hip Navigation |
| Peerless Surgical INC. | $4,443.07 | 2021-2023 | |
| Prodigy Surgical Distribution, INC. | $1,200.00 | 2021 | |
| Depuy Synthes Sales INC. | $76.03 | 2025 | Tfn-Advance, Monovisc, Orthovisc |
| Seapearl East, INC | $73.42 | 2021 | |
| Bioventus LLC | $47.51 | 2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Music City Medical Technologies, LLC | $14.96 | 2025 | |
| Kerecis Limited | $13.19 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maximilian Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.